298 top medical experts on Globoid Cell Leukodystrophy across 34 countries and 31 U.S. states, including 165 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Globoid Cell Leukodystrophy: An autosomal recessive metabolic disorder caused by a deficiency of galactosylceramidase leading to intralysosomal accumulation of galactolipids such as galactosylceramides and psychosine. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of myelin disrupts normal conduction of nerve impulses.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Sphingolipidoses (136), Hereditary Central Nervous System Demyelinating Diseases (1,644).
  4. Clinical Trials ClinicalTrials.gov : at least 19 including 5 Active, 6 Completed, 5 Recruiting
  5. Synonyms: Diffuse Globoid Body Sclerosis,  Galactosylceramidase Deficiency Disease,  Krabbe Disease


  

        

                    


    Computing Expert Listing ...

);